Dexamethasone inhibits endotoxin‐induced coagulopathy in human lungs

Abstract

Essentials Glucocorticoids are associated with an increased risk of thrombosis.Healthy volunteers received dexamethasone or placebo in an endotoxin lung instillation model.Dexamethasone suppressed thrombin generation in bronchoalveolar lavage.Glucocorticoids inhibit endotoxin induced pulmonary coagulopathy. SummaryBackgroundActivation of local and systemic coagulation is a common finding in patients with pneumonia. There is evidence that glucocorticoids have procoagulant activity in the circulation, particularly in the context of inflammation. The effects of glucocorticoids on local pulmonary coagulation have not yet been investigated.ObjectiveTo use a human model of lung inflammation based on the local instillation of endotoxin in order to investigate whether glucocorticoids alter pulmonary coagulation.MethodsTwenty‐four healthy volunteers were randomized to receive either dexamethasone or placebo in a double‐blind trial. Endotoxin was instilled via bronchoscope into right or left lung segments, followed by saline into the contralateral site. Six hours later, a bilateral bronchoalveolar lavage (BAL) was performed and coagulation parameters were measured.ResultsEndotoxin induced activation of coagulation in the bronchoalveolar compartment: the level of prothrombin fragment 1 + 2 (F1 + 2) was increased three‐fold (248 pmol L−1, 95% confidence interval [CI] 43–454 versus 743 pmol L−1, 95% CI 437–1050) and the level of thrombin–antithrombin complex (TATc) was increased by ~ 50% (31 μg L−1, 95% CI 18–45 versus 49 μg L−1, 95% CI 36–61) as compared with saline‐challenged segments. Dexamethasone reduced F1 + 2 (284 pmol L−1, 95% CI 34–534) and TATc (9 μg L−1, 95% CI 0.7–17) levels almost to those measured in BAL fluid from the saline‐instilled segments in the placebo group. Dexamethasone even profoundly reduced F1 + 2 levels (80%) in saline‐instilled lung segments (50 pmol L−1, 95% CI 12–87). In contrast, dexamethasone had no effect on systemic F1 + 2 levels.ConclusionsDexamethasone inhibits endotoxin‐induced coagulopathy in lungs. This trial is the first to provide insights into the effects of glucocorticoids on pulmonary coagulation in response to endotoxin.

Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

“…Dexamethasone has been shown to reduce sepsis-induced coagulation activation in the lungs, among other anti-inflammatory actions. 52 The effect of heparin in limiting progression to ARDS observed in this study was predominantly due to fewer patients developing bilateral pulmonary infiltrates, suggesting heparin might also limit progression of pulmonary oedema. 53 Of particular current interest, the spike protein of SARS-CoV-2 and other associated coronaviruses have been shown to bind to heparan sulphate receptors expressed by respiratory epithelial cells, leading to cellular invasion.…”

Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers

“…For subjects enrolled in the open-label study cohorts, bronchoscopic sampling was performed to obtain BAL fluid either on days 1 and 30 or on days 2 and 8, according to the current guidelines (22, 23) and as described previously (24). During bronchoscopy, a total of 100 to 300 ml of prewarmed sterile isotonic saline was instilled and retrieved in three to five aliquots through the bronchoscope from the middle lobe or the lingula.…”

Endothelial Response to Glucocorticoids in Inflammatory Diseases

“…GCs failed to attenuate the LPS-induced coagulation cascade in a human model of sepsis (177). In contrast, Bartko and coauthors showed that GCs locally reduce coagulation in a human model of lung inflammation with LPS (181). Different experimental settings used in these studies may in part explain contradictory results.…”